Germline mutations in the breast and ovarian cancer susceptibility genes BRCA1 (MIM 113705)3 and BRCA2 (MIM 600185)4, 5 confer a high risk of developing breast and ovarian cancers. This evidence concerns the gene BRCA1 and ovarian carcinoma.